<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>anti-TNF-α therapy &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/anti-tnf-%ce%b1-therapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 06 Oct 2025 05:37:09 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>anti-TNF-α therapy &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>cDC3s Impair Anti-TNF-α Therapy in Ulcerative Colitis</title>
		<link>https://bioengineer.org/cdc3s-impair-anti-tnf-%ce%b1-therapy-in-ulcerative-colitis/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 06 Oct 2025 05:36:38 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[anti-TNF-α therapy]]></category>
		<category><![CDATA[cDC3s]]></category>
		<category><![CDATA[immune dysregulation]]></category>
		<category><![CDATA[single-cell RNA sequencing]]></category>
		<category><![CDATA[ulcerative colitis]]></category>
		<guid isPermaLink="false">https://bioengineer.org/cdc3s-impair-anti-tnf-%ce%b1-therapy-in-ulcerative-colitis/</guid>

					<description><![CDATA[In a groundbreaking study published in the Journal of Translational Medicine, researchers have unveiled significant insights into the role of different immune cell populations in ulcerative colitis (UC) and their response to anti-tumor necrosis factor-alpha (anti-TNF-α) therapy. The study conducted by Li, Ma, Nie, and their team leverages cutting-edge single-cell RNA sequencing technology to elucidate [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">276154</post-id>	</item>
	</channel>
</rss>
